Skip to main content
. 2025 Mar 20;16:1535182. doi: 10.3389/fphar.2025.1535182

TABLE 1.

Patient characteristics.

Characteristics CHD patients (n = 16) Healthy donors (n = 16) p value for trend
Age, yrs 59.88 ± 10.77 53.44 ± 6.89 0.055
Female, n (%) 8 (50%) 9 (56.25%) 1.00
Body mass index, kg/m2 24.55 ± 1.80 24.37 ± 3.14 0.846
Blood pressure, mmHg
Systolic 122.88 ± 8.43 126.38 ± 8.37 0.248
Diastolic 70.00 ± 6.78 81.94 ± 7.51 0.000
Comorbidity, n (%)
Prior MI 4 (25%) 0
Prior PCI 3 (18.75%) 0
Prior CABG 1 (6.25%) 0
Prior stroke 1 (6.25%) 0
Hypertension 6 (37.5%) 0
Diabetes mellitus 2 (12.5%) 0
Hyperlipoidemia 5 (31.25%) 0
Current smoker 2 (12.5%) 3 (18.75%)
Drinking history 7 (43.75%) 5 (31.25%)
Previous antiplatelet medication, n (%)
Aspirin 7 (43.75%) 0
Clopidogrel 2 (12.5%) 0
Current Medication,n (%)
Beta-blocker 2 (12.5%) 0
Nitrates 2 (12.5%) 0
Statins 12 (75%) 0
Calcium-channel blocker 5 (31.25%) 0
ACEI 1 (6.25%) 0
ARB 1 (6.25%) 0
Hypoglycemic drugs 2 (12.5%) 0
Trimetazidine 1 (6.25%) 0
Laboratory data
WBC, 109/L 6.33 ± 1.34 8.35 ± 11.90 0.506
RBC, 1012/L 4.61 ± 0.40 4.67 ± 0.40 0.724
HGB, g/L 141.50 ± 13.13 142.13 ± 11.54 0.887
PLT, 109/L 259.25 ± 51.14 226.44 ± 42.53 0.058
PCT, % 0.26 ± 0.05 0.24 ± 0.04 0.173
PDW, fL 10.96 ± 1.11 12.26 ± 2.62 0.084
MPV, fL 10.03 ± 0.52 10.50 ± 1.09 0.136
P-LCR, % 24.70 ± 4.43 28.52 ± 8.46 0.120
TG, mmol/L 1.38 ± 0.93 1.07 ± 0.32 0.22
TC, mmol/L 4.45 ± 0.97 4.48 ± 0.77 0.921
HDL-C, mmol/L 1.23 ± 0.29 1.23 ± 0.25 0.979
LDL-C, mmol/L 2.45 ± 0.70 2.73 ± 0.50 0.208
BUN, mmol/L 14.95 ± 7.26 13.52 ± 2.59 0.465
CR, mmol/L 73.38 ± 20.81 67.93 ± 10.90 0.361
UA,mmol/L 357.38 ± 116.38 252.64 ± 53.86 0.003
PT, sec 10.84 ± 0.49 10.91 ± 0.41 0.669
PTA, % 110.81 ± 6.58 113.97 ± 17.65 0.508
INR 0.94 ± 0.04 0.94 ± 0.04 0.786
APTT, sec 26.77 ± 1.76 28.18 ± 1.61 0.025
TT, sec 17.05 ± 0.61 17.41 ± 0.33 0.047
Fbg, g/L 3.13 ± 0.72 2.61 ± 0.39 0.020
Echocardiography
LAD, mm 36.44 ± 3.97 33.06 ± 2.57 0.008
IVST, mm 8.56 ± 0.63 8.25 ± 0.86 0.249
LVD, mm 49.00 ± 4.62 46.06 ± 3.11 0.043
LVPWT, mm 8.50 ± 0.52 8.25 ± 0.86 0.325
RVPWT, mm 4 4
LVEF, % 62.13 ± 4.56 67.06 ± 3.92 0.003